Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. If you are wondering whether ...
CHICAGO, Jan. 21, 2026 /PRNewswire/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, today ...
"Sysmex's hemostasis solutions bring together advanced technology, trusted reagents and award-winning service to provide laboratories with reliable results for diagnosing patients suffering from ...
"Timely hemostasis testing is crucial for diagnosing patients suspected of suffering from bleeding or clotting disorders," said Dan Zortman, CEO of Sysmex America. "Sysmex's CN-Series was designed ...
NEW YORK — Sysmex America said Wednesday that it has received licensing from Health Canada for its CN-3000 and CN-6000 automated blood coagulation analyzers. The CN-3000 and CN-6000 are designed for ...
Relative depth of invasion (RDI) index and clinicopathologic predictive factors for identifying high axillary nodal burden in ACOSOG Z0011–eligible breast cancer patients. Primary and secondary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results